Moscow, August 20, 2020 – The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and the Gamaleya National Research Institute of Epidemiology and Microbiology have launched an information section about the human adenovirus vaccine platform on the website of the world’s first registered vaccine against coronavirus, “Sputnik V”